FDA Product Code DHX: System, Test, Carcinoembryonic Antigen
Leading manufacturers include Beckman Coulter, Inc., Dade Behring, Inc. and bioMerieux, Inc..
28
Total
28
Cleared
119d
Avg days
1980
Since
Declining activity -
0 submissions in the last 2 years
vs 2 in the prior period
FDA 510(k) Cleared System, Test, Carcinoembryonic Antigen Devices (Product Code DHX)
28 devices
Cleared
Sep 22, 2023
Access CEA
Beckman Coulter, Inc.
Immunology
267d
Cleared
Aug 23, 2023
VITROS Immunodiagnostic Products CEA Reagent Pack
Ortho-Clinical Diagnostics
Immunology
90d
Cleared
Apr 13, 2020
ADVIA Centaur CEA Assay
Siemens Healthcare Disgnostics, Inc.
Immunology
76d
Cleared
Oct 09, 2008
VIDAS CEA (S) ASSAY
bioMerieux, Inc.
Immunology
258d
Cleared
Jun 25, 2008
DIMENSION VISTA CARCINOEMBRYONIC ANTIGEN FLEX REAGENT CARTRIDGE (CEA)
Dade Behring, Inc.
Immunology
379d
Cleared
May 06, 2003
ACCESS CEA REAGENTS FOR USE ON THE ACCESS IMMUNOASSAY SYSTEMS
Beckman Coulter, Inc.
Immunology
15d
Cleared
May 11, 1999
ABBOTT ARCHITECT CEA
Abbott Laboratories
Immunology
63d
Cleared
Sep 24, 1998
ACCESS CEA REAGENTS ON THE ACCESS IMMUNOASSAY ANALYZER MODEL 33200, 33205, 33206 & 33209
Beckman Coulter, Inc.
Immunology
111d
Cleared
Jun 29, 1998
ELECSYS CEA ON THE ELECSYS 1010
Boehringer Mannheim Corp.
Immunology
112d
Cleared
Sep 22, 1997
IMMULITE CEA
Diagnostic Products Corp.
Immunology
196d
Cleared
Aug 03, 1981
THREE LEVEL CONTROL SERA
Bd Becton Dickinson Vacutainer Systems Preanalytic
Immunology
164d
About Product Code DHX - Regulatory Context
510(k) Submission Activity
28 total 510(k) submissions under product code DHX since 1980, with 28 receiving FDA clearance (average review time: 119 days).
Submission volume has declined in recent years - 0 submissions in the last 24 months compared to 2 in the prior period.